EUVIMEDEUVIMED entdecken
Crossref

Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus

Sylwia Tabor, Mikołaj Piwowarczyk

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.113815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Sylwia Tabor und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tabor, S., & Piwowarczyk, M. (2026). Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.113815

Vancouver

Tabor S, Piwowarczyk M. Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.113815

BibTeX
@article{Tabor2026,
  author = {Tabor, Sylwia and Piwowarczyk, Mikołaj},
  title = {Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.113815}
}
Kostenlos starten →